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Abstract 
Aims. Since desmin expression is diminished in vascular smooth muscle cells during 
reparative processes, we wanted to study whether a common intragenic single nucleotide 
polymorphism (SNP) at nucleotide position 828 (rs1058261) of the DES gene associates 
with hypertension, cerebrovascular complications, and all cardiovascular events in the 
Tampere adult population cardiovascular risk study (TAMRISK). 
Materials and Methods. A Finnish periodic health examination cohort of 336 subjects with 
diagnosed hypertension and 473 controls was analyzed. Samples were genotyped for the 
polymorphism using TaqMan techniques. Prevalence of ischemic heart diseases, 
incidence of cerebrovascular diseases, and transient cerebral ischemic attacks (TIA) were 
followed up obtained by self-report and the National Hospital Discharge Registry (HILMO) 
Results. There was no association of rs1058261 genotypes with hypertension at the age 
of 50. When the subjects were followed up to the age of 60, after adjustment for gender 
and BMI, subjects with genotype CC had higher incidence of cerebrovascular events 
(cerebrovascular diseases and TIA) (4.1%), compared to the T-allele (1.6%) (p=0.046). 
Also, those with genotype CC had higher incidence of all combined cardiovascular events 
(12.8%) compared to the subjects with the T-allele (8.5%) (p=0.028).  
Conclusions. Our findings suggest that the variations in the DES gene may be involved in 
cardiovascular disease.  
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Introduction 
Desmin (DES) is a muscle-specific intermediate filament (IF) protein that connects cell 
organelles by forming a cytoskeletal network. It is expressed in skeletal, cardiac and 
smooth muscle cells (SMC) (Raguz et al. 1998, Fichna et al. 2014). Desmin is a useful 
marker for SMC differentiation (Nikkari et al. 1988). The only cells found in the media of 
normal human arteries are SMCs, responsible for arterial structure, function, and repair 
(Ross. 1999).  In order to be able to meet the various requirements, the arterial SMC is 
capable of expressing different phenotypes, the extremes of which have been termed 
“contractile” and “synthetic”, based on their functional and morphological characteristics 
(Campbell and Campbell. 1990). A biochemical characterization of the SMC phenotypes 
has been achieved by studying the expression of muscle-related proteins (i.e. desmin and 
α-actin) in various states of smooth muscle (Allahverdian et al. 2018). In the majority of 
human atherosclerotic plaques, SMCs are desmin negative (Dartsch et al. 1989).  
Desmin is encoded by the DES gene located on chromosome 2q35. DES encompasses 
nine exons within an 8.4-kb region and codes for 476 amino acids (Li et al. 1989). Since 
the recognition of the involvement of the DES gene in human disease in 1998 (Goldfarb et 
al. 1998), the number of publications on different DES mutations and associated 
phenotypes has increased steadily (van Spaendonck-Zwarts et al. 2011). We wanted to 
study whether a common intragenic single nucleotide polymorphism (SNP) at nucleotide 
position 828 (rs1058261) of the DES gene (Fichna et al. 2014) associates with 
hypertension, cerebrovascular complications and all combined cardiovascular events in a 
Finnish population from the Tampere adult population cardiovascular risk study 
(TAMRISK). 
Materials and Methods 
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Subjects 
TAMRISK study data was collected from periodic health examinations (PHE) done for 50-
year-old men and women living in Tampere, a city in southern Finland with 220 000 
inhabitants (Maatta et al. 2015). At the PHE in 2003 by a public health nurse, height (cm) 
and weight (kg) were recorded from which the body mass index (BMI) was calculated. 
Blood pressure measurement (mmHg) was done using a calibrated mercury 
sphygmomanometer. Serum glucose (mmoles/l), and total cholesterol, HDL-cholesterol, 
triglycerides (from which LDL-cholesterol was calculated by the Friedewald formula) were 
measured after an overnight fast by standard techniques. An interview was conducted 
using a structured questionnaire about health and health-related behavior. Buccal swabs 
for DNA extraction and a permissions form to use PHE information and national registry 
data were collected by mail separately of the physical examination during years 2006–
2010. Using the patient's national identity code, data on hospitalizations including ICD-10 
codes for discharge diagnoses were obtained from the National Hospital Discharge 
Registry (HILMO) maintained by the National Institute of Health and Welfare. Prevalence 
of ischemic heart diseases (I20-I25), incidence of cerebrovascular diseases (I60-I69), and 
transient cerebral ischemic attacks (TIAs) (G45) were followed up from 2005 to 2014 until 
the subjects were on the average 60 years old. In follow-up of the genotyped subjects, 
there were 67 with ischemic heart disease, 15 who had a diagnosis of cerebrovascular 
disease and 8 with TIA. The subjects with cerebrovascular disease and TIA were 
combined for the group with cerebrovascular events. All participants gave informed 
consent and the Ethics Committees of the Tampere University Hospital and the City of 
Tampere approved the study. 
Cases (n=336) were subjects who had hypertension at the age of 50 years (as diagnosed 
by a physician) and for each case, at least one normotensive control subject (n=473) with 
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the same sex, and similar smoking habits, was chosen in order of admission from the PHE 
cohort (n=6000). The present study population at the age of 50 years thus included 809 
subjects.  
Genotyping 
DNA was extracted from buccal swabs using a commercial kit (Qiagen Inc., Valencia, 
Calif., USA). An intragenic SNP at nucleotide position 828 (rs1058261) of the desmin gene 
was chosen (Fichna et al. 2014). For DNA genotyping, PCR was performed in a final 
volume of 5 µl containing 10 ng of sample DNA, 0.05 µl of custom SNP-specific Assay mix 
and 2.18 µl of Taqman Universal PCR Master Mix. The Assay mix used was 
C__11735969_20. Amplification proceeded for 40 cycles of 15 s at 95°C and 60 s at 60°C. 
Genotyping followed the Applied Biosystems (Pleasanton, CA, USA) protocol. Automatic 
genotype call was performed after PCR, by scanning plates on the 7900 HT Fast Real-
Time PCR, which provides the SDS2.3 software (Applied Biosystems). 
Statistical analysis 
Logistic regression, one-way ANOVA or T-test for continuous variables and Chi-square 
test or Fisher’s exact test for categorical variables were applied for the comparison of 
cases, controls and genotype groups. Analyses were carried out using SPSS 23.0 for 
Windows (SPSS Inc., Chicago, Illinois, USA). 
Results 
Clinical characteristics of case group of 336 hypertensive subjects and 473 controls at the 
age of 50 years have been previously described (Kunnas et al. 2012).  Samples were 
available and genotyping for rs1058261 was successful for 809 subjects: 336 cases and 
473 controls (351 women and 458 men). The genotype frequencies were CC: 421 
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(52.0%), CT 329 (40.7%), and TT 59 (7.3%). The genotypes were in Hardy-Weinberg 
equilibrium (Chi-square=0.23, p>0.05).  
There was no association of rs1058261 genotypes with hypertension when all genotypes 
were compared with each other (p=0.235); when CC genotype was compared to combined 
CT+TT genotypes (p=0.987); or when TT genotype was compared to combined CT+CC 
genotypes (p=0.102).  
When the subjects were followed up to the age of 60, subjects with genotype CC had 
higher incidence of cerebrovascular events (4.0%), compared to the T-allele (1.5%) 
(p=0.031) (Table 1). When incidence of cerebrovascular events was adjusted by BMI and 
gender, the OR for CC genotype was 2.63 (p=0.046, CI 1.018 – 6.78), compared to T-
allele carriers.  
At the age of 60, those with genotype CC had also higher incidence of all combined 
cardiovascular events (12.6%) compared to the subjects with the T-allele (8.5%) (p=0.052) 
(Table 1). When adjusted by BMI and gender, the OR for CC genotype was 1.72 (p=0.028, 
CI 1.06-2.79) compared to T-allele carriers.  
DES rs1058261 did not associate with other background characteristics of the study 
population (Table 1). 
Discussion  
The DES intragenic SNP (C>T) at nucleotide position 828 (rs1058261) is a synonymous 
codon that does not lead to amino acid change. However, it may be possible that 
rs1058261 is in linkage disequilibrium with a functional polymorphism that could lead to 
pathological changes at the protein level, since we report that this variation is associated 
with cerebrovascular complications and all combined cardiovascular events. At the age of 
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60, those with genotype CC had higher incidence of these events compared to subjects 
with the T-allele. However, there was no association of this SNP with hypertension. 
Previously, the C allele of the benign DES rs1058261 was associated with myofibrillar 
myopathies in two Polish families having other pathological mutations in the DES gene 
(Fichna et al. 2014). It is thought that intimal smooth muscle cells (SMCs) in native 
atherosclerotic plaque derive mainly from the medial arterial layer. Smooth muscle 
involvement is not reported as the main manifestation in DES related myopathy, but some 
manifestations that indicate smooth muscle involvement have been reported, like 
swallowing difficulties (Goldfarb et al. 1998).  
Numerous research groups have used a variety of in vivo and in vitro model systems and 
clinical studies to demonstrate the conversion of normally contractile vascular SMC during 
phenotypic modulation to a less differentiated state, capable of proliferation, migration, and 
extracellular matrix secretion. These changes in vascular SMC phenotype are thought to 
underlie many vascular occlusive diseases (Nguyen et al. 2013). Phenotypic switching of 
the SMC plays a major role in a number of major diseases in humans including 
atherosclerosis and hypertension (Owens et al. 2004). Phenotype of the arterial smooth 
muscle cell in various stages of modulation or repair during fetal development, ageing, and 
atherosclerosis is characterized by “synthetic” SMCs that are rich in synthetic organelles 
and desmin-negative (Nikkari. 1991). Thus, variation in the expression of desmin may be 
considered important in the repair and function of the arterial wall. This may be influenced 
by the SNP DES rs1058261 since it was associated with cardiovascular events. 
A weakness of the present study is the relatively small population, and few cases of 
cerebrovascular complications. Nevertheless, these cases were manifested at a relatively 
young age, with possible genetic predisposition. In conclusion, we report for the first time, 
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that the DES gene may be involved in cardiovascular disease as well, in addition to 
muscular disease (Goldfarb et al. 1998). 
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Table 1. Clinical characteristics (means ± SD) of the study population stratified according to DES rs1058261 genotypes. 
 
 CC (421) CT (329)  TT (59) P value * 
CC vs. 
CT vs. 
TT 
P value * 
CC vs. 
(CT+TT) 
P value * 
TT vs.  
(CC +CT)  
P value ** 
CC vs. 
(CT+TT) 
Cerebrovascular events % (n) 4.0 (17) 1.5 (5) 1.7 (1) 0.097 0.031 1.000 0.046 
All combined cardiovascular events % (n) 12.6 (53) 8.2 (27) 10.2 (6) 0.138 0.052 0.881 0.028 
        
Body mass index kg/m2 (SD) 26.7 (4.5) 26.6 (4.4) 26.5 (4.7) 0.868 0.604 0.790  
Glucose, mmol/L (SD) 5.03 (1.13) 5.00 (1.18) 4.93 (0.90) 0.810 0.620 0.585  
Cholesterol, mmol/L (SD) 5.39 (0.99) 5.40 (0.99) 5.47 (0.83) 0.823 0.695 0.563  
Systolic blood pressure, mmHg (SD) 135.5 (17.7) 133.7 (16.3) 135.4 (17.8) 0.370 0.219 0.766  
Diastolic blood pressure, mmHg (SD) 87.6 (10.5) 87.6 (9.3) 89.1 (11.4) 0.553 0.834 0.279  
 
SD, standard deviation. * Chi-square test, Fisher’s exact test, One-way ANOVA or T-test. ** Logistic regression adjusted by BMI and gender. P 
values <0.05 are in bold. 
 
